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Abstract 
The number of traumatic thoracic aortic injuries being treated by endovascular 
procedures is on the rise. Coronavirus (COVID-19) has affected healthcare 
systems worldwide and was declared a global pandemic by the world health 
organization (WHO) in March 2020. In this study, we discuss a 37-year-old 
man with thoracic aorta trauma caused by a motor–vehicle accident that 
underwent Thoracic endovascular aortic repair (TEVAR) and was incidentally 
diagnosed with concurrent COVID-19. During this pandemic period, 
physicians should be on the lookout for COVID-19 with low thresholds for 
testing, as a timely diagnosis will improve patient outcomes and reduce the risk 
of transmission. A delay in diagnosis puts the patients at risk of not receiving 
effective treatment and may result in the transmission of infection to hospital 
staff, environment (i.e. operating rooms and equipment), and other members of 
the community. 
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Blunt traumatic aortic injury, a surgical emergency 
with a high mortality rate has been reported in 
acceleration-deceleration injuries. It is most commonly 
seen in motor vehicle accidents (1, 2). Thoracic 
endovascular aortic repair (TEVAR) has been 
established as a treatment for blunt traumatic aortic 
injury. It lowers mortality and morbidity in comparison 
with open repair (2, 3). Coronavirus (COVID-19) was 
first recognized in Wuhan, China in December 2019 
and has since spread worldwide being labeled as a 
global pandemic by the world health organization 
(WHO) in March 2020. It is highly contagious with 
symptoms ranging from mild to severe respiratory 
distress and death (4-7). The first patient with COVID-
19 in Iran was officially reported in February 2020 and 
shortly after COVID-19 outbreak became evident in 
Iran (6-8). 
Patients admitted to hospitals for vascular 
emergencies with concurrent undiagnosed COVID-19 
infections are challenging as the infection complicates 
the diagnosis, pre, and post-operation course (8, 9). 
In this study, we present a 37-year-old man with 
traumatic a thoracic aortic injury caused by a motor –
vehicle accident that underwent TEVAR and was 
incidentally diagnosed with concurrent COVID-19. 
His legal attorney completed an informed consent form 
for publication of case details and images after his 
death. 
1. Department of Radiology, Clinical 
Research and Development Center, 
Shahid Modarres Hospital, Shahid 
Beheshti University of Medical 
Sciences, Tehran, Iran. 
2. Department of General Surgery, 
Critical Care Quality Improvement 
Research Center, Shahid Modarres 
Hospital, Shahid Beheshti University 





Corresponding Author:  
Nasser Malekpour Alamdari, MD, 
Department of General Surgery, 
Critical Care Quality Improvement 
Research Center, Shahid Modarres 
Hospital, Shahid Beheshti University of 




Besharat et al.                                                                                          COVID-19 in a Traumatic Thoracic Aortic Injury Patient 
 Journal of Cellular & Molecular Anesthesia (JCMA) 
198 
Case Report 
A 37-year-old Iranian man riding a motorcycle was hit 
by a car and referred to Modarres Hospital, Tehran, 
Iran for dissection and pseudoaneurysm repair in aortic 
arch descending thoracic aorta (Figure 1-A and 1-B). 
Due to his concerning unstable hemodynamic status, 
the patient was scheduled for emergent endovascular 
treatment just a few days before the COVID-19 
outbreak in Iran in February 2020. He was unconscious 
due to diffuse axonal injury that was seen on his brain 
magnetic resonance imaging (MRI).  
He was suffering from low blood pressure and 
bilateral hemothorax as well. He was febrile at the time 
of admission. Angiography with Computed Axial 
Tomography (CT angiography) showed dissecting 
intimal flap in distal of aortic arch and 
pseudoaneurysm at aortic isthmus. Bilateral collapse 
consolidation was visualized in lung bases as well 
(Figure 2).  
After primitive management TEVAR by a 
board-certified vascular surgeon with advanced 
endovascular skills was performed in the operating 
room under general anesthesia via left-sided common 
femoral artery access to the aorta. The endovascular 
stent graft was placed in the aortic arch and proximal 
descending thoracic aorta covering more than 95% left 
subclavian artery origin, using a Cook Zenith Alpha 
ZTA -P-28-109W graft; with a length of 109 mm and 
an Introducer Sheath ID/OD Fr (mm)/mm; COOK 
MEDICAL LLC, Bloomington, IN, United States; 
Figure 3A and 3B. The stent-graft was positioned 
perfectly and dissecting intimal flap and 
pseudoaneurysm were excluded and covered. The end 
angiography was normal.  
He was admitted to ICU for a postoperative 
course. His fever persisted for the days to follow and 
we encountered an unfounded lymphopenia and high 
C-reactive protein whilst the patient's hemoglobin 
remained stable. Another CT angiography was 
performed, revealing bilateral multilobar ground-glass 
opacities and consolidations lacking specific 
distribution. We supposed that they could be 
attributable to pulmonary contusion and superimposed 
infection (Figure 4A, 4B, 4C, and 4D). The patient's 
condition deteriorated and he did not respond to 
 
Figure 1. 1A, 1B: VR and MIP reconstruction of preoperative CT angiography depicting pseudoaneurysm. 
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ordinary treatments. Meanwhile, the COVID-19 
outbreak was announced officially in Iran; so, the 
patient's nasopharyngeal swab specimens were 
performed for reverse transcription-polymerase chain 
reaction (RT-PCR) analysis, leading to early COVID-
19 confirmed diagnosis. 
Discussion 
COVID-19 outbreak has affected healthcare 
systems globally as they face new challenges regarding 
diagnosis and treatment of affected patients, especially 
 
Figure 2. Collapse consolidation in lung bases associated with hemothorax bilaterally. 
 
Figure 3. A, B: VR and MIP reconstruction of postoperative CT angiography with stent graft. 
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that are asymptomatic or admitted to hospitals for 
reasons other than COVID-19 (9). 
Cardiopulmonary conditions, diabetes, 
immunocompromised status, and obesity are 
considered risk factors for severe illness (5, 10); 
however, there is no evidence that surgery imposes a 
higher risk for severe illness on patients. Common 
traumatic and postoperative complications may mimic 
the pulmonary symptoms of COVID-19 potentially 
delaying a positive diagnosis (11). Pulmonary 
contusion, aspiration pneumonia, pulmonary emboli, 
pulmonary edema, viral and bacterial pneumonia are 
some conditions with similar radiographic 
presentations to COVID -19. 
It seems prudent that during a pandemic period 
physicians should have a lower threshold for testing, as 
a timely diagnosis will improve patient outcomes and 
reduce the risk of transmission (4). A delay in 
diagnosis puts the patients at risk of not receiving 
effective treatment and may result in the transmission 
of infection to hospital staff, environment (i.e. 
operation rooms and equipment), and other members 
of the community (12). 
Since the effect of COVID-19 in the 
postoperative course is unknown, it is unclear whether 
vascular surgeries should be performed during the 
pandemic period. Life-threatening conditions such as 
ruptured symptomatic thoracic aorta aneurysm or 
 
Figure 4. A, B, C and D: bilateral multi lobar ground glass opacities and consolidations in post-operative course. 
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abdominal aorta aneurysm, aortic dissection, and 
pseudoaneurysm should not be postponed according to 
the American College of Surgery guidelines, whilst 
others believe that we can shorten the peak time and 
reduce the number of new infections by avoiding 
surgery (13). 
On the other hand, vascular pathology is a 
major potential source of disease pathophysiology in 
COVID-19 with an important role in the global patient 
outcome; hence the term is known as “COVID-19-
associated endotheliopathy” has been coined (14-16) 
The prerequisite for SARS-CoV-2 infection is 
the angiotensin-converting enzyme 2 (ACE2) 
receptors; these receptors are abundantly found on the 
surface of endothelial cells; which would be the exact 
receptor for the virus. This leads to increased 
coagulation and severe endothelial inflammation. In 
pathologic findings, the following items found in 
COVID-19-associated endotheliopathy (14-16): 
 extensive thrombosis associated with 
microangiopathy 
 severe cellular level injuries in the endothelial 
vascular layer 
 escalated vascular angiogenesis 
 
Considering the above findings, it is a delicate 
balance between risks and benefits. The risk 
assessment analysis will be conducted by the vascular 
surgery team who will need to consider the 
risks/benefits for surgical candidates on one hand and 
the risks/benefits for society and the health care system 
on the other hand.  
Conclusion 
During this pandemic period, physicians should be on 
the lookout for COVID-19 with low thresholds for 
testing, as a timely diagnosis will improve patient 
outcomes and reduce the risk of transmission. 
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